SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-009272
Filing Date
2022-01-31
Accepted
2022-01-31 08:32:39
Documents
13
Period of Report
2022-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm224898d1_8k.htm   iXBRL 8-K 25611
2 EXHIBIT 99.1 tm224898d1_ex99-1.htm EX-99.1 10677
  Complete submission text file 0001104659-22-009272.txt   213423

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fencf-20220131.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20220131_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20220131_pre.xml EX-101.PRE 22594
7 EXTRACTED XBRL INSTANCE DOCUMENT tm224898d1_8k_htm.xml XML 3636
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 22571451
SIC: 2836 Biological Products, (No Diagnostic Substances)